For more information, email us at info@girsinc.com or call us at 901-834-9119. GIRS tracks payer market mergers and other trends[…]
Read more
Category: Future Trends
4.7 Million Could Become Eligible for Medicaid – What Does that Mean for Market Access?
Recent data released by the Kaiser Family Foundation (KFF) points to continued Medicaid payer market expansion. There also is the[…]
Read more
Washington State Health Care Authority to Make Final Coverage Determinations on Three Recent Technology Assessments
The Washington State Health Technology Clinical Committee (HTCC) determines how selected health technologies are covered by several state agencies (RCW[…]
Read more
CMS Announces Billing Guidelines for Prosthetic Feet, Lower Limb Extremity Prostheses-Knee-Shin Prosthesis
Billing codes and guidelines are dynamic and should be tracked every year. For Medicare claims, the Centers for Medicare and[…]
Read moreDrug Advertisement Must Mention Drug Price – Proposed CMS Rule
The Centers for Medicare & Medicaid Services (CMS) released a proposed rule, titled Medicare and Medicaid Programs: Drug Pricing Transparency,[…]
Read moreGIRS Gears Up to Assist Clients to Track and Address Potential Challenges the Pharmaceutical Industry Will Face in 2019
As we near the end of this year, we at GIRS are thinking of ways to support our clients better[…]
Read moreChanges to the Medicare Local Coverage Determination Process Pave the Way to Expand Access to New Medical Technologies
As part of a broader effort to modernize the Medicare program and bring the latest technologies and innovations to Medicare[…]
Read moreMarket Access Support for 2 Biologic Technologies Results in a Medical Coverage Policy, Benefits 8 Million Federal Employees
The GIRS Payer Advocacy® (PAC) team began working with a key payer in 2013 on coverage and payment after our[…]
Read morePayer Interest Grows as Medicare Advantage Enrollment Continues to Increase, Showing Signs of a Stable Market
Medicare beneficiaries can elect to have their healthcare coverage administered either through traditional Medicare (also referred to as Original Medicare)[…]
Read moreFDA Launches Complex Innovative Designs Pilot Meeting Program in Effort to Advance Clinical Trials of Drugs and Biologics
August 29, the U.S. Food and Drug Administration announced a new program, Complex Innovative Designs Pilot Meeting Program or CIDPMP. […]
Read more